Mizuho Medy Co.,Ltd.
Mizuho Medy Co.,Ltd. Fundamental Analysis
Mizuho Medy Co.,Ltd. (4595.T) shows strong financial fundamentals with a PE ratio of 10.16, profit margin of 30.42%, and ROE of 19.64%. The company generates $11.3B in annual revenue with moderate year-over-year growth of 4.00%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 68.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 4595.T's fundamental strength across five key dimensions:
Efficiency Score
Excellent4595.T demonstrates superior asset utilization.
Valuation Score
Excellent4595.T trades at attractive valuation levels.
Growth Score
Weak4595.T faces weak or negative growth trends.
Financial Health Score
Excellent4595.T maintains a strong and stable balance sheet.
Profitability Score
Moderate4595.T maintains healthy but balanced margins.
Key Financial Metrics
Is 4595.T Expensive or Cheap?
P/E Ratio
4595.T trades at 10.16 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 4595.T's PEG of 0.47 indicates potential undervaluation.
Price to Book
The market values Mizuho Medy Co.,Ltd. at 1.86 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 9.31 times EBITDA. This is generally considered low.
How Well Does 4595.T Make Money?
Net Profit Margin
For every $100 in sales, Mizuho Medy Co.,Ltd. keeps $30.42 as profit after all expenses.
Operating Margin
Core operations generate 41.27 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $19.64 in profit for every $100 of shareholder equity.
ROA
Mizuho Medy Co.,Ltd. generates $15.31 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Mizuho Medy Co.,Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Mizuho Medy Co.,Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
4595.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
10.16
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.47
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.86
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.09
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
7.36
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.20
vs 25 benchmark
ROA
Return on assets percentage
0.15
vs 25 benchmark
ROCE
Return on capital employed
0.24
vs 25 benchmark
How 4595.T Stacks Against Its Sector Peers
| Metric | 4595.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 10.16 | 28.25 | Better (Cheaper) |
| ROE | 19.64% | 780.00% | Weak |
| Net Margin | 30.42% | -20122.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.30 | Strong (Low Leverage) |
| Current Ratio | 7.36 | 4.66 | Strong Liquidity |
| ROA | 15.31% | -14687.00% (disorted) | Strong |
4595.T outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Mizuho Medy Co.,Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
77.83%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
331.53%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
349.41%
Industry Style: Defensive, Growth, Innovation
High Growth